Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
67.43
-1.75 (-2.53%)
Apr 7, 2025, 2:10 PM EDT - Market open

Insmed Statistics

Total Valuation

Insmed has a market cap or net worth of $12.19 billion. The enterprise value is $12.40 billion.

Market Cap 12.19B
Enterprise Value 12.40B

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

Insmed has 181.00 million shares outstanding. The number of shares has increased by 16.81% in one year.

Current Share Class 181.00M
Shares Outstanding 181.00M
Shares Change (YoY) +16.81%
Shares Change (QoQ) +3.05%
Owned by Insiders (%) 0.88%
Owned by Institutions (%) 100.74%
Float 166.41M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 31.20
Forward PS 26.22
PB Ratio 43.48
P/TBV Ratio 105.66
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 34.09
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.45, with a Debt / Equity ratio of 4.59.

Current Ratio 5.45
Quick Ratio 4.99
Debt / Equity 4.59
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -9.24

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -29.31%
Return on Invested Capital (ROIC) -37.49%
Return on Capital Employed (ROCE) -45.53%
Revenue Per Employee $286,158
Profits Per Employee -$718,939
Employee Count 1,271
Asset Turnover 0.22
Inventory Turnover 0.94

Taxes

In the past 12 months, Insmed has paid $3.71 million in taxes.

Income Tax 3.71M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +140.60% in the last 52 weeks. The beta is 1.07, so Insmed's price volatility has been similar to the market average.

Beta (5Y) 1.07
52-Week Price Change +140.60%
50-Day Moving Average 77.53
200-Day Moving Average 73.75
Relative Strength Index (RSI) 28.94
Average Volume (20 Days) 1,647,992

Short Selling Information

The latest short interest is 14.47 million, so 7.99% of the outstanding shares have been sold short.

Short Interest 14.47M
Short Previous Month 14.62M
Short % of Shares Out 7.99%
Short % of Float 8.69%
Short Ratio (days to cover) 7.29

Income Statement

In the last 12 months, Insmed had revenue of $363.71 million and -$913.77 million in losses. Loss per share was -$5.57.

Revenue 363.71M
Gross Profit 277.97M
Operating Income -786.57M
Pretax Income -799.73M
Net Income -913.77M
EBITDA -777.70M
EBIT -786.57M
Loss Per Share -$5.57
Full Income Statement

Balance Sheet

The company has $1.43 billion in cash and $1.31 billion in debt, giving a net cash position of $123.88 million or $0.68 per share.

Cash & Cash Equivalents 1.43B
Total Debt 1.31B
Net Cash 123.88M
Net Cash Per Share $0.68
Equity (Book Value) 285.38M
Book Value Per Share 1.59
Working Capital 1.32B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$683.88 million and capital expenditures -$21.92 million, giving a free cash flow of -$705.81 million.

Operating Cash Flow -683.88M
Capital Expenditures -21.92M
Free Cash Flow -705.81M
FCF Per Share -$3.90
Full Cash Flow Statement

Margins

Gross margin is 76.43%, with operating and profit margins of -216.26% and -251.24%.

Gross Margin 76.43%
Operating Margin -216.26%
Pretax Margin -250.22%
Profit Margin -251.24%
EBITDA Margin -213.82%
EBIT Margin -216.26%
FCF Margin n/a

Dividends & Yields

Insmed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -16.81%
Shareholder Yield -16.81%
Earnings Yield -7.30%
FCF Yield -5.64%
Dividend Details

Analyst Forecast

The average price target for Insmed is $95.36, which is 41.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target $95.36
Price Target Difference 41.57%
Analyst Consensus Strong Buy
Analyst Count 16
Revenue Growth Forecast (5Y) 66.59%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on March 3, 2011. It was a reverse split with a ratio of 0.1:1.

Last Split Date Mar 3, 2011
Split Type Reverse
Split Ratio 0.1:1

Scores

Insmed has an Altman Z-Score of -0.28 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.28
Piotroski F-Score 4